A New Synthetic Analogue of Protectin DX With Enhanced Therapeutic Potential Against Metabolic‐Associated Steatotic Liver DiseaseFrédérik Desmarais(Lung Institute), André Marette(Université Laval)The FASEB JournalOctober 26, 202510.1096/fj.202502152rrrrCited by 0SaveCiteExport RISWatch citationsRelated PapersObese Mice Lacking Inducible Nitric Oxide Synthase Are Sensitized to the Metabolic Actions of Peroxisome Proliferator–Activated Receptor-γ Agonism|Diabetes|2008|63